Возможности негормональной терапии в коррекции проявлений климактерического синдрома

Вазомоторные симптомы в периоде менопаузального перехода встречаются у 80% женщин и могут длиться годами, что серьезно снижает качество жизни. Типичными жалобами пациенток являются приливы жара, повышенная потливость, а также нарушения сна. Лечение и коррекция проблем менопаузального перехода — важные задачи для акушера-гинеколога. На сегодняшний день менопаузальная гормональная терапия является золотым стандартом в купировании приливов и профилактике остеопороза, однако у нее есть противопоказания. Для тех категорий женщин, которые не могут или не хотят из личных предпочтений принимать гормональные препараты, должны быть предложены негормональные альтернативные методы.

В статье представлен обзор возможных вариантов медикаментозного и немедикаментозного воздействия, а также обсуждаются доказательства эффективности и безопасности альтернативных средств, в том числе коррекция диеты с использованием комплекса растительных компонентов и витаминов Эстровэл с целью предотвращения патологического течения климакса и профилактики возраст-ассоциированных состояний. Поиск литературы осуществляли в отечественных (eLibrary, CyberLeninka.ru) и международных (PubMed, Cochrane Library) базах данных. Преимущественным являлся свободный доступ к полному тексту публикаций. Преимущество отдавалось источникам периода 2018–2025 гг., однако в список литературы включены работы, датированные ранее.

1. Юренева С.В., Ильина Л.М., Эбзиева З.Х. Менопаузальные вазомоторные симптомы: социальные аспекты, динамика, кардиометаболические риски и возможности гормональной терапии. // Акушерство и гинекология. — 2019. — №1. — С.26-32. doi: https://doi.org/10.18565/aig.2019.L26-32

2. Rossouw JE, Anderson GL, Prentice RL, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women’s Health Initiative randomized controlled trial. JAMA. 2002;288(3):321-33. doi: https://doi.org/10.1001/jama.288.3.321

3. Pinkerton JV. Hormone therapy for postmenopausal women. N Engl J Med. 2020;382(5):446–55. doi: https://doi.org/10.1056/NEJMcp1714787

4. Murtaza F, Shirreff L, Huang LN, et al. Quality and readability of online health information on menopausal hormone therapy in Canada: what are our patients reading? Menopause. 2021;29:54-62. doi: https://doi.org/10.1097/GME.0000000000001881

5. “The 2023 Nonhormone Therapy Position Statement of The North American Menopause Society” Advisory Panel. The 2023 nonhormone therapy position statement of The North American Menopause Society. Menopause. 2023;30(6):573-590. doi: https://doi.org/10.1097/GME.0000000000002200

6. Российское общество акушеров-гинекологов. Клинические рекомендации «Менопауза и климактерическое состояние у женщины». 2021 г. https://cr.minzdrav.gov.ru/view-cr/117_2?ysclid=mb7ygm319s416903155

7. Strelow B, O’Laughlin D, Anderson T, et al. Menopause Decoded: What’s Happening and How to Manage It. J Prim Care Community Health. 2024;15:21501319241307460. doi: https://doi.org/10.1177/21501319241307460

8. Lederman S, Ottery FD, Cano A, et al. Fezolinetant for treatment of moderate-to-severe vasomotor symptoms associated with menopause (SKYLIGHT 1): a phase 3 randomised controlled study. Lancet. 2023;401(10382):1091-1102. doi: https://doi.org/10.1016/S0140-6736(23)00085-5

9. Besong C, Philippeaux S, Bham A, et al. Managing Menopause: The Evolving Role of Estrogens, Selective Serotonin Reuptake Inhibitors, and Phytoestrogens in Balancing Hormonal Fluctuations. Cureus. 2024;16(9):e70440. doi: https://doi.org/10.7759/cureus.70440

10. Chen MN, Lin CC, Liu CF. Efficacy of phytoestrogens for menopausal symptoms: a meta-analysis and systematic review. Climacteric. 2015;18:260–269. doi: https://doi.org/10.3109/13697137.2014.966241

11. Reed SD, Lampe JW, Qu C, et al. Self-reported menopausal symptoms in a racially diverse population and soy food consumption. Maturitas. 2013;75(2):152–158. doi: https://doi.org/10.1016/j.maturitas.2013.03.003

12. Xiang Z, Ma B, Pei X, et al. Mechanism of action of genistein on breast cancer and differential effects of different age stages. Pharm Biol. 2025;63(1):141-155. doi: https://doi.org/10.1080/13880209.2025.2469607

13. Mukund V, Behera SK, Alam A, et al. Molecular docking analysis of nuclear factor-κB and genistein interaction in the context of breast cancer. Bioinformation. 2019;15(1):11–17. doi: https://doi.org/10.6026/97320630015011

14. Chen M, Li S, Srinivasasainagendra V, et al. Maternal soybean genistein on prevention of later-life breast cancer through inherited epigenetic regulations. Carcinogenesis. 2022;43(3):190–202. doi: https://doi.org/10.1093/carcin/bgac009

15. Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–249. doi: https://doi.org/10.3322/caac.21660

16. Wan MLY, Co VA, El-Nezami H. Endocrine disrupting chemicals and breast cancer: a systematic review of epidemiological studies. Crit Rev Food Sci Nutr. 2022:62(24):6549–6576. doi: https://doi.org/10.1080/10408398.2021.1903382

17. Shu XO, Zheng Y, Cai H, et al. Soy food intake and breast cancer survival. JAMA. 2009;302(22):2437-2443. doi: https://doi.org/10.1001/jama.2009.1783

18. Chen LR, Ko NY, Chen KH. Isoflavone Supplements for Menopausal Women: A Systematic Review. Nutrients. 2019;11(11):2649. doi: https://doi.org/10.3390/nu11112649

19. Simon JA, Davis SR, Lindén Hirschberg A, et al. State of the art in menopause: current best practice approaches from the IMS World Congress 2024, Melbourne. Climacteric. 2025;28(2):98-103. doi: https://doi.org/10.1080/13697137.2025.2457993

20. Thurston RC, Aslanidou Vlachos HE, Derby CA, et al. Menopausal Vasomotor Symptoms and Risk of Incident Cardiovascular Disease Events in SWAN. J Am Heart Assoc. 2021;10(3):e017416. doi: https://doi.org/10.1161/JAHA.120.017416

21. Blanco Mejia S, Messina M, Li SS, et al. A meta-analysis of 46 studies identified by the FDA demonstrates that soy protein decreases circulating LDL and total cholesterol concentrations in adults. J. Nutr. 2019;149(6):968–981. doi: https://doi.org/10.1093/jn/nxz020

22. Naghshi S, Tutunchi H, Yousefi M, et al. Soy isoflavone intake and risk of cardiovascular disease in adults: A systematic review and dose-response meta-analysis of prospective cohort studies. Crit Rev Food Sci Nutr. 2024;64(18):6087-6101. doi: https://doi.org/10.1080/10408398.2022.2163372

23. Viscardi G, Back S, Ahmed A, et al. Effect of Soy Isoflavones on Measures of Estrogenicity: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Adv Nutr. 2025;16(1):100327. doi: https://doi.org/10.1016/j.advnut.2024.100327

24. Кузнецова И.В., Войченко Н.А., Кириллова М.Ю. Качество жизни и кардиоваскулярный риск у женщин в периодах менопаузального перехода и постменопаузы. // Медицинский алфавит. — 2020. — №4. — С.39-45

25. Татарова Н.А., Айрапетян М.С., Жигалова Е.В. Стартовая терапия климактерического синдрома переходного менопаузального периода. // РМЖ. Мать и дитя. — 2017. — Т. 25. — №2. — С. 98–103

26. Shi V, Morgan EF. Estrogen and estrogen receptors mediate the mechanobiology of bone disease and repair. Bone. 2024;188:117220. doi: https://doi.org/10.1016/j.bone.2024.117220

27. Aaseth JO, Finnes TE, Askim M, et al. The Importance of Vitamin K and the Combination of Vitamins K and D for Calcium Metabolism and Bone Health: A Review. Nutrients. 2024;16(15):2420. doi: https://doi.org/10.3390/nu16152420

28. Zoch ML, Clemens TL, Riddle RC. New insights into the biology of osteocalcin. Bone. 2016;82:42–49. doi: https://doi.org/10.1016/j.bone.2015.05.046

29. Feskanich D, Weber P, Willett WC, et al. Vitamin K intake and hip fractures in women: a prospective study. Am J Clin Nutr. 1999;69(1):74-9. doi: https://doi.org/10.1093/ajcn/69.1.74

30. Torbergsen AC, Watne LO, Wyller TB, et al. Vitamin K1 and 25 (OH) D are independently and synergistically associated with a risk for hip fracture in an elderly population: A case control study. Clin. Nutr. 2015;34:101–106. doi: https://doi.org/10.1016/j.clnu.2014.01.016

31. Baez-Gonzalez AS, Carrazco-Carrillo JA, Figueroa-Gonzalez G, et al. Functional effect of indole-3 carbinol in the viability and invasive properties of cultured cancer cells. Biochem Biophys Rep. 2023;35:101492. doi: https://doi.org/10.1016/j.bbrep.2023.101492

32. Brandi G, Paiardini M, Cervasi B, et al. A new indole-3-carbinol tetrameric derivative inhibits cyclin-dependent kinase 6 expression, and induces G1 cell cycle arrest in both estrogen-dependent and estrogen-independent breast cancer cell lines. Cancer Res. 2003;63:4028–4036

33. Seyoum Tola F. The concept of folic acid supplementation and its role in prevention of neural tube defect among pregnant women: PRISMA. Medicine (Baltimore). 2024;103(19):e38154. doi: https://doi.org/10.1097/MD.0000000000038154

34. Thornburgh S, Gaskins AJ. B vitamins, polycystic ovary syndrome, and fertility. Curr Opin Endocrinol Diabetes Obes. 2022;29(6):554-559. doi: https://doi.org/10.1097/MED.0000000000000773

35. Ismail S, Eljazzar S, Ganji V. Intended and Unintended Benefits of Folic Acid Fortification-A Narrative Review. Foods. 2023;12(8):1612. doi: https://doi.org/10.3390/foods12081612

36. Kaye AD, Jeha GM, Pham AD, et al. Folic Acid Supplementation in Patients with Elevated Homocysteine Levels. Adv. Ther. 2020;37:4149–4164. doi: https://doi.org/10.1007/s12325-020-01474-z

37. Fu P, Gibson CJ, Mendes WB, et al. Anxiety, depressive symptoms, and cardiac autonomic function in perimenopausal and postmenopausal women with hot flashes: a brief report. Menopause. 2018;25:12:1470-1475. doi: https://doi.org/10.1097/GME.0000000000001153

38. Bromberger JT, Kravitz HM, Chang Y, et al. Does risk for anxiety increase during the menopausal transition? Study of Women’s Health Across the Nation. Menopause. 2013;20:5:488-495. doi: https://doi.org/10.1097/GME.0b013e3182730599

39. Khalili P, Asbaghi O, Aghakhani L, et al. The effects of folic acid supplementation on depression in adults: A systematic review and meta-analysis of randomized controlled trials. Nutr. Food Sci. 2023;53:521–534. doi: https://doi.org/10.1108/NFS-02-2022-0043

40. Maki PM, Jaff NG. Brain fog in menopause: a healthcare professional’s guide for decision-making and counseling on cognition. Climacteric. 2022;25(6):570–578. doi: https://doi.org/10.1080/13697137.2022.2122792

41. Islam MT, Al Shamsh Prottay A, Bhuia MS, et al. Memory-Enhancing Effects of Daidzin, Possibly Through Dopaminergic and AChEergic Dependent Pathways. J Nutr. 2025:S0022-3166(25)00269-X. doi: https://doi.org/10.1016/j.tjnut.2025.04.024

42. Uddenberg ER, Safwan N, Saadedine M, et al. Menopause transition and cardiovascular disease risk. Maturitas. 2024;185:107974. doi: https://doi.org/10.1016/j.maturitas.2024.107974

43. Thurston RC, Chang Y, Kline CE, et al. Trajectories of sleep over midlife and incident cardiovascular disease events in the Study of Women’s Health Across the Nation. Circulation. 2024;149:7: 545-555. doi: https://doi.org/10.1161/CIRCULATIONAHA.123.066491

44. Martins FO, Conde SV. Gender differences in the context of obstructive sleep apnea and metabolic diseases. Front Physiol. 2021;12:792633. doi: https://doi.org/10.3389/fphys.2021.792633

45. Maffei ME. 5-Hydroxytryptophan (5-HTP): Natural Occurrence, Analysis, Biosynthesis, Biotechnology, Physiology and Toxicology. Int J Mol Sci. 2020;22(1):181. doi: https://doi.org/10.3390/ijms22010181

46. Cerqueira RO, Frey BN, Leclerc E, et al. Vitex agnus castus for premenstrual syndrome and premenstrual dysphoric disorder: a systematic review. Arch Womens Ment Health. 2017;20:713–719. doi: https://doi.org/10.1007/s00737-017-0791-0

47. Höller M, Steindl H, Abramov-Sommariva D, et al. Use of Vitex agnus-castus in patients with menstrual cycle disorders: a single-center retrospective longitudinal cohort study. Arch Gynecol Obstet. 2024 May;309(5):2089-2098. doi: https://doi.org/10.1007/s00404-023-07363-4

48. Soleimany Z, Siadat F, Farhadi M, et al. Improvement of ovarian function in a premature ovarian failure mouse model using Vitex agnus-castus extract. JBRA Assist Reprod. 2025;29(1):117-126. doi: https://doi.org/10.5935/1518-0557.20240101

49. Kumari R, Thakur A, Thakur P, et al. An Update on the Nutritional and Therapeutic Potential of Dioscorea oppositifolia. Food Sci Nutr. 2025;13(5):e70179. doi: https://doi.org/10.1002/fsn3.70179

50. Lu J, Wong RN, Zhang L, et al. Comparative Analysis of Proteins with Stimulating Activity on Ovarian Estradiol Biosynthesis from Four Different Dioscorea Species in vitro Using Both Phenotypic and Target-based Approaches: Implication for Treating Menopause. Appl Biochem Biotechnol. 2016;180(1):79-93. doi: https://doi.org/10.1007/s12010-016-2084-x